CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions		Sep. 30, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents ($256 and $146 related to variable interest entities ("VIEs"))		$ 677	$ 520
Restricted cash and cash equivalents	[1]	333	325
Accounts receivable—trade, net ($107 and $29 related to VIEs)		935	932
Accounts receivable—other ($36 and $57 related to VIEs)		209	175
Contracts in progress ($223 and $144 related to VIEs)		1,063	704
Project-related intangible assets, net		68	137
Inventory		52	101
Other current assets ($32 and $24 related to VIEs)		149	139
Total current assets		3,486	3,033
Property, plant and equipment, net		2,118	2,067
Operating lease right-of-use assets		361
Accounts receivable—long-term retainages		49	62
Investments in unconsolidated affiliates		450	452
Goodwill		1,335	2,654	[2]
Other intangibles, net		790	1,009
Other non-current assets		165	163
Total assets		8,754	9,440
Current liabilities:
Revolving credit facility		801
Debt		3,450	30
Lease obligations		161	8
Accounts payable ($322 and $277 related to VIEs)		1,421	595
Advance billings on contracts ($497 and $717 related to VIEs)		1,359	1,954
Project-related intangible liabilities, net		24	66
Accrued liabilities ($66 and $136 related to VIEs)		1,517	1,564
Total current liabilities		8,733	4,217
Long-term debt			3,393
Long-term lease obligations		301	66
Deferred income taxes		51	47
Other non-current liabilities		778	664
Total liabilities		9,863	8,387
Commitments and contingencies
Mezzanine equity:
Redeemable preferred stock		271	230
Stockholders' equity:
Common stock, par value $1.00 per share, authorized 255 shares; issued 185 and 183 shares, respectively		185	183
Capital in excess of par value		3,554	3,539
Accumulated deficit		(4,822)	(2,719)
Accumulated other comprehensive loss		(222)	(107)
Treasury stock, at cost: 3 and 3 shares, respectively		(96)	(96)
Total McDermott Stockholders' Equity		(1,401)	800
Noncontrolling interest		21	23
Total stockholders' equity		(1,380)	823
Total liabilities and stockholders' equity		$ 8,754	$ 9,440

[1] Our restricted cash balances primarily serve as cash collateral deposits for our letter of credit facilities. See Note 12, Debt, for further discussion.

[2] As of December 31, 2018, we had approximately $2.2 billion of cumulative impairment charges recorded in conjunction with our impairment assessment performed during the fourth quarter of 2018, as further described in the 2018 Form 10-K